Nuclear Medicine: Page 72

GE, Lantheus launch phase III trial for flurpiridaz

By AuntMinnie.com staff writers

GE Healthcare and Lantheus Medical Imaging have launched a second phase III clinical trial for Lantheus' flurpiridaz F-18 investigational PET radiopharmaceutical.

July 30, 2018

USP proposes new radiopharmaceutical standards

By AuntMinnie.com staff writers

The U.S. Pharmacopeial Convention (USP) has published its proposal for revised minimum standards on the preparation, compounding, dispensing, and repackaging of sterile and nonsterile radiopharmaceuticals.

July 30, 2018

SNMMI awards technologists

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held several award ceremonies for its technologist section during the recent annual meeting in Philadelphia.

July 29, 2018

Global nuclear medicine groups chart the future

By AuntMinnie.com staff writers

A weeklong meeting of nuclear medicine societies and organizations from around the world resulted in a number of recommendations to advance priorities that include training and education.

July 29, 2018

Russia, South Africa partner on radioisotope deal

By AuntMinnie.com staff writers

Russian atomic energy firm Rosatom and South African Nuclear Energy have signed an agreement to build two nuclear reactors in South Africa for the production of medical isotopes.

July 26, 2018

NRC publishes rules on medical byproducts

By AuntMinnie.com staff writers

The U.S. Nuclear Regulatory Commission (NRC) has published the final rule and guidance on how to deal with the medical use of nuclear byproducts by providing recommendations on training and adopting common terms and definitions.

July 26, 2018

RadioMedix, ITM ink radiopharmaceutical generator deal

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and Isotopen Technologien München (ITM) subsidiary Isotope Technologies Garching have signed an agreement to manufacture and supply germanium-68 and gallium-68 generators.

July 25, 2018

FLT-PET points toward survival for glioblastoma patients

By Wayne Forrest

PET scans with the radiotracer F-18 fluorothymidine (FLT) can help determine which glioblastoma patients have the best chance for longer survival, according to a study published online on July 21 in the European Journal of Nuclear Medicine and Molecular Imaging.

July 25, 2018

NorthStar wins FDA nod for RadioGenix production

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has received U.S. Food and Drug Administration (FDA) approval to manufacture its RadioGenix isotope separation system at the firm's headquarters facility in Beloit, WI. It has also formally launched the system, which can produce technetium-99m from nonuranium-based molybdenum-99.

July 24, 2018

Australian agency orders review of Mo-99 procedures

By Brian Casey

An Australian government agency has ordered a review of radiation safety procedures at another federal agency in charge of running the nuclear reactor that was forced to stop shipments of the radioisotope molybdenum-99 (Mo-99) last month. The halt has spurred an ongoing shortage of important radiopharmaceuticals in the country.

July 19, 2018

SNMMI touts JNM's rising impact factor

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is highlighting growth of the impact factor for its Journal of Nuclear Medicine, which is again among the top-ranked worldwide medical imaging journals based on Clarivate Analytics' 2017 "Journal Citation Reports."

July 18, 2018

Support urged for funding for U.S. Mo-99 supply

By AuntMinnie.com staff writers

A consortium of radiology associations, patient advocacy groups, and radiology vendors are strongly urging the U.S. Senate and House subcommittees on energy and water development to support funding for molybdenum-99 (Mo-99) production in the country.

July 18, 2018

Previous Page

Page 72 of 438

Next Page